News tagged with relapse rates


Natalizumab shows promise for teens with multiple sclerosis

(HealthDay)—Natalizumab may be safe in pediatric multiple sclerosis (MS) patients with highly active disease, according to a small study published online Feb. 18 in JAMA Neurology.

Neuroscience created Feb 22, 2013 | popularity 5 / 5 (3) | comments 0

Landmark study in blood stem cell transplant

(Medical Xpress)—Before all the excitement about embryonic stem cells, doctors were using hematopoetic – that is, blood-forming—stem cells. Hematopoetic stem cells can replenish all the types of cells in the blood, ...

Medical research created Jan 04, 2013 | popularity 5 / 5 (2) | comments 0 | with audio podcast

Antipsychotics do help many with schizophrenia, study finds

(HealthDay) -- A new study finds that antipsychotic drugs can help many people with schizophrenia, cutting patients' risk of relapse by 60 percent.

Psychology & Psychiatry created May 03, 2012 | popularity 3 / 5 (2) | comments 0 | with audio podcast

Multiple sclerosis drug disappoints on disability

(Medical Xpress) -- This week the Journal of the American Medical Association published a study with unfortuate news for the millions of people who suffer from multiple sclerosis. In the large study, a therapy known as inte ...

Neuroscience created Jul 23, 2012 | popularity 5 / 5 (1) | comments 0

A new treatment option for alcohol dependence: Reduced consumption rather than abstinence

A potential new treatment for alcoholism called nalmefene is effective and safe for reducing alcohol consumption in alcohol dependent individuals, says a new study published this week in Biological Psychiatry.

Psychology & Psychiatry created Apr 11, 2013 | popularity 5 / 5 (1) | comments 1

Cigarette pack health warnings can help ex-smokers stave off urge to resume smoking

Health warnings on cigarette packs can help ex-smokers stave off the urge to start smoking again, indicates research published online in Tobacco Control.

Addiction created Apr 25, 2012 | popularity 1 / 5 (1) | comments 0